Page last updated: 2024-08-21

podophyllotoxin and Squamous Cell Carcinoma of Head and Neck

podophyllotoxin has been researched along with Squamous Cell Carcinoma of Head and Neck in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Chae, JI; Jeon, YJ; Park, S; Seo, JH; Shim, JH; Yoon, G1
Cho, SD; Choi, SJ; Shin, JA; Yu, HJ1
Clayburgh, DR; Gross, ND; Koide, J; Proby, C; Wong, MH1

Other Studies

3 other study(ies) available for podophyllotoxin and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Deoxypodophyllotoxin Induces ROS-Mediated Apoptosis by Modulating the PI3K/AKT and p38 MAPK-Dependent Signaling in Oral Squamous Cell Carcinoma.
    Journal of microbiology and biotechnology, 2022, Sep-28, Volume: 32, Issue:9

    Topics: Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Flavonolignans; Head and Neck Neoplasms; Humans; Mouth Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Podophyllotoxin; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck

2022
Podophyllotoxin reduces the aggressiveness of human oral squamous cell carcinoma through myeloid cell leukemia‑1.
    International journal of molecular medicine, 2023, Volume: 52, Issue:5

    Topics: Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Leukemia; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Myeloid Cells; Podophyllotoxin; Squamous Cell Carcinoma of Head and Neck

2023
Effects of epidermal growth factor receptor and insulin-like growth factor 1 receptor inhibition on proliferation and intracellular signaling in cutaneous SCCHN: potential for dual inhibition as a therapeutic modality.
    Head & neck, 2013, Volume: 35, Issue:1

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; ErbB Receptors; Erlotinib Hydrochloride; Fluorescent Antibody Technique; Head and Neck Neoplasms; Humans; Insulin-Like Growth Factor Binding Protein 1; Podophyllotoxin; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Squamous Cell Carcinoma of Head and Neck

2013